Axa
AMPH icon

Axa’s Amphastar Pharmaceuticals AMPH Stock Holding History

Axa’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-29,678
Closed -$1.3M – 1062
2024
Q1 		$1.3M Sell
29,678
-2,500
-8% -$129K ﹤0.01% 809
2023
Q4 		$1.99M Sell
32,178
-30,722
-49% -$1.61M 0.01% 735
2023
Q3 		$2.89M Sell
62,900
-12,700
-17% -$693K 0.01% 648
2023
Q2 		$4.34M Sell
75,600
-76,255
-50% -$3.38M 0.01% 585
2023
Q1 		$5.69M Buy
151,855
+2,449
+2% +$80.3K 0.02% 531
2022
Q4 		$4.19M Buy
149,406
+3,141
+2% +$91.2K 0.02% 649
2022
Q3 		$4.11M Buy
146,265
+66,396
+83% +$2.17M 0.02% 616
2022
Q2 		$2.78M Buy
+79,869
New +$2.85M 0.01% 717

Other funds holding AMPH

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return